Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 2040685

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2040685

Sleep Aids Market Size, Share & Trends Analysis Report By Product (Medications, Sleep Therapy Devices), By Disorder (Insomnia, Obstructive Sleep Apnea, Narcolepsy, Parasomnias), By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Sleep Aids Market Summary

The global sleep aids market size was valued at USD 49.1 billion in 2025 and is projected to reach USD 95.2 billion by 2033, growing at a CAGR of 8.7% from 2026 to 2033. The increasing incidence of sleep disorders, including insomnia, sleep apnea, and restless leg syndrome, is a key factor driving the growth of the industry.

According to an article published in June 2025, under the National Center for Biotechnology Information, approximately 852 million adults globally suffer from insomnia, accounting for a global prevalence of around 16.2%, these data highlight the substantial patient population requiring diagnosis and treatment.

Insomnia remains the most common disorder, driven by factors such as anxiety, depression, and irregular sleep cycles. In addition, the growing prevalence of sleep apnea, closely linked to obesity and cardiovascular diseases, is increasing the demand for medical devices such as CPAP systems. As diagnosis rates improve and awareness increases, more patients are seeking treatment, thereby driving demand across pharmaceuticals, devices, and sleep-support products. This high disease

prevalence, combined with its association with chronic conditions such as cardiovascular diseases and mental health disorders, is driving demand for:

  • Prescription sleep medications
  • CPAP and sleep apnea devices
  • Diagnostic and monitoring solutions

In addition, modern lifestyle patterns, characterized by high stress, long working hours, and excessive screen exposure, are significantly contributing to poor sleep quality. Rapid urbanization and digitalization have disrupted circadian rhythms, leading to delayed sleep onset and reduced sleep duration. The widespread use of smartphones and digital devices before bedtime suppresses melatonin production, further aggravating sleep disorders. Therefore, a growing number of consumers are actively seeking solutions such as sleep medications, supplements, and wearable sleep technologies. This shift toward proactive sleep management is accelerating the adoption of both clinical and consumer sleep aids, thereby supporting sustained market growth.

Global Sleep Aids Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global sleep aids market report on the basis of product, disorder, distribution channel, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Medications
  • Sleep Therapy Devices
    • Positive Airway Pressure (PAP) Devices
    • Oral Appliances
    • Wearable Sleep Trackers
  • Sleep Environment Products
  • Sleep Laboratory & Diagnostic Services
  • Disorder Outlook (Revenue, USD Million, 2021 - 2033)
  • Insomnia
  • Obstructive Sleep Apnea (OSA)
  • Narcolepsy
  • Parasomnias (e.g., Sleepwalking, Night Terrors)
  • Restless Legs Syndrome (RLS)
  • Other Sleep Disorders
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce Platforms
  • Drug Stores
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-890-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Disorder
    • 1.1.3. Distribution Channel
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Sleep Aids Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Sleep Aids Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Sleep Aids Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Sleep Aids Market by Product Outlook
  • 4.4. Medications
    • 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5. Sleep Therapy Devices
    • 4.5.1. Positive Airway Pressure (PAP) Devices
      • 4.5.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 4.5.2. Oral Appliances
      • 4.5.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 4.5.3. Wearable Sleep Trackers
      • 4.5.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.6. Sleep Environment Products
    • 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.7. Sleep Laboratory & Diagnostic Services
    • 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Sleep Aids Market: Disorder Estimates & Trend Analysis

  • 5.1. Disorder Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Sleep Aids Market by Disorder Outlook
  • 5.4. Insomnia
    • 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5. Obstructive Sleep Apnea (OSA)
    • 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.6. Narcolepsy
    • 5.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.7. Parasomnias (e.g., Sleepwalking, Night Terrors)
    • 5.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.8. Restless Legs Syndrome (RLS)
    • 5.8.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Sleep Aids Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Distribution Channel Market Share, 2025 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Global Sleep Aids Market by Distribution Channel Outlook
  • 6.4. Hospital Pharmacies
    • 6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 6.6. E-Commerce Platforms
    • 6.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 6.7. Drug Stores
    • 6.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Sleep Aids Market: Regional Estimates & Trend Analysis, By product, By disorder, By Distribution Channel

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Key company market share/position analysis, 2025
  • 8.3. Company Profiles
    • 8.3.1. Merck & Co., Inc.
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Pfizer Inc.
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Sanofi S.A.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. GSK plc
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Takeda Pharmaceutical Company Limited
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Teva Pharmaceutical Industries Ltd.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Koninklijke Philips N.V.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. ResMed Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Fisher & Paykel Healthcare Corporation Limited
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Drive DeVilbiss Healthcare LLC
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Compumedics Limited
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Cadwell Industries, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Tempur World, LLC
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-890-7

List of Tables

  • Table 1 List of abbreviation
  • Table 2 List of secondary sources
  • Table 3 North America Sleep Aids Market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 5 North America Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 6 North America Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 7 U.S. Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 8 U.S. Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 9 U.S. Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 10 Canada Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 11 Canada Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 12 Canada Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 13 Mexico Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 14 Mexico Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 15 Mexico Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 16 Europe Sleep Aids Market, by country, 2021 - 2033 (USD Million)
  • Table 17 Europe Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 18 Europe Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 19 Europe Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 20 Germany Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 21 Germany Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 22 Germany Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 23 UK Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 24 UK Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 25 UK Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 26 France Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 27 France Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 28 France Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 29 Italy Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 30 Italy Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 31 Italy Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 32 Spain Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 33 Spain Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 34 Spain Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 35 Denmark Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 36 Denmark Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 37 Denmark Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 38 Sweden Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 39 Sweden Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 40 Sweden Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 41 Norway Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 42 Norway Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 43 Norway Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific Sleep Aids Market, by country, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 48 China Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 49 China Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 50 China Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 51 Japan Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 52 Japan Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 53 Japan Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 54 India Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 55 India Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 56 India Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 57 South Korea Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 58 South Korea Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 59 South Korea Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 60 Australia Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 61 Australia Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 62 Australia Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 63 Thailand Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 64 Thailand Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 65 Thailand Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 66 Latin America Sleep Aids Market, by country, 2021 - 2033 (USD Million)
  • Table 67 Latin America Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 68 Latin America Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 69 Latin America Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 70 Brazil Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 71 Brazil Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 72 Brazil Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 73 Argentina Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 74 Argentina Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 75 Argentina Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 76 MEA Sleep Aids Market, by country, 2021 - 2033 (USD Million)
  • Table 77 MEA Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 78 MEA Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 79 MEA Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 80 South Africa Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 81 South Africa Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 82 South Africa Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 86 UAE Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 87 UAE Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 88 UAE Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 89 Kuwait Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 90 Kuwait Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 91 Kuwait Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Sleep Aids Market: market outlook
  • Fig. 9 Cryostat competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Sleep aids market driver impact
  • Fig. 15 Sleep aids market restraint impact
  • Fig. 16 Sleep aids market strategic initiatives analysis
  • Fig. 17 Sleep aids market: Product movement analysis
  • Fig. 18 Sleep aids market: Product outlook and key takeaways
  • Fig. 19 Medications market estimates and forecast, 2021 - 2033
  • Fig. 20 Sleep therapy devices market estimates and forecast, 2021 - 2033
  • Fig. 21 Positive airway pressure (PAP) Devices market estimates and forecast, 2021 - 2033
  • Fig. 22 Oral appliances market estimates and forecast, 2021 - 2033
  • Fig. 23 Wearable sleep trackers market estimates and forecast, 2021 - 2033
  • Fig. 24 Sleep environment products market estimates and forecast, 2021 - 2033
  • Fig. 25 Sleep laboratory & diagnostic services market estimates and forecast, 2021 - 2033
  • Fig. 26 Sleep aids market: Disorder movement analysis
  • Fig. 27 Sleep aids market: Disorder outlook and key takeaways
  • Fig. 28 Insomnia market estimates and forecast, 2021 - 2033
  • Fig. 29 Obstructive sleep apnea market estimates and forecast, 2021 - 2033
  • Fig. 30 Narcolepsy market estimates and forecast, 2021 - 2033
  • Fig. 31 Parasomnias market estimates and forecast, 2021 - 2033
  • Fig. 32 Restless legs syndrome market estimates and forecast, 2021 - 2033
  • Fig. 33 Other sleep disorder market estimates and forecast, 2021 - 2033
  • Fig. 34 Sleep Aids Market: Distribution Channel movement analysis
  • Fig. 35 Sleep Aids Market: Distribution Channel outlook and key takeaways
  • Fig. 36 Hospital Pharmacies market estimates and forecast, 2021 - 2033
  • Fig. 37 Retail Pharmacies market estimates and forecast, 2021 - 2033
  • Fig. 38 E-Commerce Platforms market estimates and forecast, 2021 - 2033
  • Fig. 39 Drug Store market estimates and forecast, 2021 - 2033
  • Fig. 40 Global Sleep Aids Market: Regional movement analysis
  • Fig. 41 Global Sleep Aids Market: Regional outlook and key takeaways
  • Fig. 42 Global Sleep Aids Market share and leading players
  • Fig. 43 North America market share and leading players
  • Fig. 44 Europe market share and leading players
  • Fig. 45 Asia Pacific market share and leading players
  • Fig. 46 Latin America market share and leading players
  • Fig. 47 Middle East & Africa market share and leading players
  • Fig. 48 North America: SWOT
  • Fig. 49 Europe SWOT
  • Fig. 50 Asia Pacific SWOT
  • Fig. 51 Latin America SWOT
  • Fig. 52 MEA SWOT
  • Fig. 53 North America, by country
  • Fig. 54 North America market estimates and forecasts, 2021 - 2033
  • Fig. 55 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 56 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 57 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 58 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 59 UK market estimates and forecasts, 2021 - 2033
  • Fig. 60 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 61 France market estimates and forecasts, 2021 - 2033
  • Fig. 62 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 63 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 64 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 65 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 66 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 67 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 68 China market estimates and forecasts, 2021 - 2033
  • Fig. 69 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 70 India market estimates and forecasts, 2021 - 2033
  • Fig. 71 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 72 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 73 Thailand market estimates and forecasts, 2021 - 2033
  • Fig. 74 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 75 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 76 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 77 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 78 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 79 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 80 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 81 Kuwait market estimates and forecasts, 2021 - 2033
  • Fig. 82 Market share of key market players- Sleep Aids Market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!